Market Highlights
Increasing prevalence of epilepsy,
rising number of traumatic brain injury cases, growing geriatric population,
and rising healthcare expenditures are the major drivers for the global
epilepsy diagnosis and treatment market. However, high cost of therapeutic
surgeries, low per capita healthcare expenditure, and lack of awareness for the
disease in emerging economies are estimated to restrain the market growth
during the projected period. The global epilepsy diagnosis and treatment market
is estimated to grow at an approximate CAGR of 6.3% during the forecast period.
Segmentation
The global epilepsy diagnosis and
treatment market is segmented on the basis of type, diagnosis, treatment, and
end-user. On the basis of type, the market is segmented into idiopathic,
cryptogenic, symptomatic, and others. On the basis of diagnosis, the market is
segmented into neurological exam, blood test, imaging, and others. The imaging
segment is sub-segmented into electroencephalogram, computerized tomography,
magnetic resonance imaging, positron emission tomography, and others. On the
basis of treatment, the market is segmented into medication, surgery, brain
stimulation, and others. The medication segment is sub-segmented into
acetazolamide, carbamazepine, clobazam, and others. The surgery segment is
sub-segmented into hemispherectomy, corpus callosotomy, resection surgery, and
others. The brain stimulation segment is sub-segmented into deep brain
stimulation, responsive neurostimulation, and others. On the basis of end user,
the market is segmented into hospitals & clinics, diagnostic centers, and
others.
Access Report Details @ https://www.marketresearchfuture.com/reports/epilepsy-diagnosis-treatment-market-5647
Regional Analysis
The Americas dominate the global
epilepsy diagnosis and treatment market, which can be attributed to the
presence of a well-developed healthcare sector and huge patient population
within the region. Moreover, increasing number of head trauma cases boosts the
American market. Europe holds the second largest market share owing to the
availability of funds for research, presence of a well-developed healthcare
sector, and government support. Followed by Europe, the Asia Pacific region is
projected to be the fastest growing region for the global epilepsy diagnosis
and treatment market. Presence of developing healthcare sector, along with
emerging economies of the Asia Pacific region boosts the market growth. The
Middle East & Africa has the least share in the global epilepsy diagnosis
and treatment market, owing to the low per capita healthcare expenditures, lack
of awareness for the disease, and stringent government policies, especially in
the African region. On the other hand, the Middle East region within the Middle
East & Africa is estimated to be fastest growing region due to growing
healthcare expenditures and presence of the developed economies, such as
Kuwait, Qatar, Dubai, and others.
Key Players
The key players for the global epilepsy diagnosis and
treatment market are Pfizer, Inc. (U.S.), Johnson & Johnson Services, Inc.
(U.S.), UCB Pharma Ltd. (U.K), Abbott (U.S.), GlaxoSmithKline plc (U.K),
Novartis International AG (Switzerland), Sanofi S.A. (France), Shire (Republic
of Ireland), Medtronic (U.S.), NeuroWave Systems Inc. (U.S.), Natus Medical
Incorporated. (U.S.), Siemens Ltd. (Germany), and others
About Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients. Our market research studies by Components,
Application, Logistics and market players for global, regional, and country
level market segments, enable our clients to see more, know more, and do more,
which help to answer all their most important questions.
In order to stay updated with
technology and work process of the industry, MRFR often plans & conducts
meet with the industry experts and industrial visits for its research analyst
members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog:
https://healthcarenews12.blogspot.com/
No comments:
Post a Comment